About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Bharat Parenterals Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
541096
ISIN Demat
INE365Y01019
Book Value
581.56
NSE Code
NA
Dividend Yield %
0.10
Market Cap
6915.05
P/E
40.86
EPS
24.56
Face Value
10
BSE
NSE
19-Mar-2026
BSE
NSE
NSE F & O
BSE
NSE
NSE F & O
Last Price
1003.35
Net Change
-7.65
% Change
-0.76%
Prev.Close
1011.00
Open
1013.00
High
1040.00
Low
1000.05
Volume
19070
Last Price
Net Change
% Change
Prev.Close
Open
High
Low
Volume
Value
19419128
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
1040.00
52-Week High
1667.20
52-Week Low
885.65
Value
Best Buy
Best Sell
Best Quantity
Sell Quantity
Today's Range
52-Week High
52-Week Low
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
26-Sep-23
29-Sep-23
Dividend
10 %
19-Sep-25
Company News
13-01-2026
Bharat Parenterals inform...
09-01-2026
Bharat Parenterals infor...
09-12-2025
Bharat Parenterals infor...
04-12-2025
Bharat Parenterals inform...
28-11-2025
FAMHP concludes EU GMP in...
27-11-2025
Bharat Parenterals inform...
04-09-2025
Bharat Parenterals inform...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.